Overview
Mojca Tajnik practices practicing medicine in Trieste, Italy.
Their clinical expertise encompasses Leber Hereditary Optic Neuropathy (LHON), Optic Nerve Atrophy, and Primary Lateral Sclerosis.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mojca Tajnik
Is Mojca Tajnik a top-rated expert for Leber Hereditary Optic Neuropathy (LHON)?
MediFind is an objective health platform that identifies experts based on real-world data. Mojca Tajnik is classified as an Experienced expert for Leber Hereditary Optic Neuropathy (LHON), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mojca Tajnik participate in research or clinical trials?
Yes. Mojca Tajnik has published 8 articles and abstracts on conditions like Leber Hereditary Optic Neuropathy (LHON). You can view a list of Mojca Tajnik's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Leber Hereditary Optic Neuropathy (LHON)
- Optic Nerve AtrophyTajnik isExperienced. Learn about Optic Nerve Atrophy.
- Primary Lateral SclerosisTajnik isExperienced. Learn about Primary Lateral Sclerosis.